Poly MedicureNSE:POLYMED +1.36%91 Gross Margin % is 66.67% as of Mar. 2026, which is 20% above its 10-year median of 55.61. GuruFocus rates NSE:POLYMED with a GF Score™ of 91/100 and a GF Value™ of ₹2,315.50 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 803 Medical Devices & Instruments companies, Poly Medicure ranks better than 62.39% on this metric.
The historical rank and industry rank for Poly Medicure's Gross Margin % or its related term are showing as below:
NSE:POLYMED'
s Gross Margin % Range Over the Past 10 Years
Min: 52.75 Med: 55.61 Max: 68.17
Current: 59.81
During the past 13 years, the highestGross Margin % of Poly Medicure was 68.17%. The lowest was 52.75%. And the median was 55.61%.
NSE:POLYMED's Gross Margin % is ranked better than 62.39% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs NSE:POLYMED: 59.81
Poly Medicure had a gross margin of 66.67% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Poly Medicure was 4.90% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Poly Medicure had a gross margin of 66.67% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Poly Medicure Gross Margin % Related Terms
Poly Medicure Gross Margin % Historical Data
* Premium members only.
The historical data trend for Poly Medicure's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:POLYMED vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Poly Medicure's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Poly Medicure Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Poly Medicure's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Poly Medicure's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Poly Medicure (NSE:POLYMED) has a Gross Margin % of 66.67% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Poly Medicure and its competitors. This is 20% above median its historical median of 55.61. Over the past decade, Poly Medicure's Gross Margin % has ranged from 52.75 to 68.17. According to the industry distribution chart, Poly Medicure ranks #302 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 37.6%.
Is Poly Medicure's Gross Margin % too high?
Poly Medicure's current Gross Margin % of 66.67% is 20% above median its 10-year median of 55.61. Over the past 10 years, this metric has ranged from a low of 52.75 to a high of 68.17. The Medical Devices & Instruments industry median Gross Margin % is 52.03. Poly Medicure's value of 66.67% is 28.1% above this industry median. Based on the distribution chart, Poly Medicure ranks #302 out of 803 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Poly Medicure has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Poly Medicure's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Poly Medicure ranks #302 out of 803 companies for Gross Margin %. This puts Poly Medicure in the upper half of its industry. The industry median Gross Margin % is 52.03. Poly Medicure's value of 66.67% is 28.1% above this benchmark. Historically, Poly Medicure's own Gross Margin % has ranged from 52.75 to 68.17 over the past decade. While the company's 10-year median is 55.61 vs. the industry median of 52.03, Poly Medicure has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Poly Medicure's current Gross Margin % of 66.67% is 28.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Poly Medicure and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Poly Medicure's current Gross Margin % is 66.67%, which is 20% above median its own 10-year median of 55.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poly Medicure stock overvalued right now?
Based on GuruFocus' analysis, Poly Medicure (NSE:POLYMED) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹2,315.50, compared to a current price of ₹1,668.30 — trading 28% below its estimated fair value. The current Gross Margin % is 66.67%, which is 20% above median its 10-year median of 55.61 and 28.1% above the Medical Devices & Instruments industry median of 52.03. Poly Medicure's overall GF Score™ is 91/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Poly Medicure (NSE:POLYMED), the current Gross Margin % is 66.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Poly Medicure (NSE:POLYMED) Overvalued in 2026?
Based on GuruFocus' analysis, Poly Medicure stock appears to be undervalued.
The current stock price of ₹1,668.30 is trading 28% below its estimated GF Value™ of ₹2,315.50.
GuruFocus considers Poly Medicure to be Modestly Undervalued.
Key valuation signals for NSE:POLYMED:
Gross Margin %: 66.67% (20% above median its 10-year median of 55.61)
GF Value™: ₹2,315.50 vs. price of ₹1,668.30 (28% below fair value)
Industry Position: 28.1% above the Medical Devices & Instruments median (#302 of 803)
No single metric tells the full story. See the NSE:POLYMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, vascular access, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.
91GF Score
Get the complete analysis for NSE:POLYMED
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:POLYMED has been successfully added to your 
